Oxford University Hospitals

Oxford OX4 2PG

5 studies enrolling now · 9 studies all time

What they study most

Adult Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Colorectal Cancer, Follicular Lymphoma (FL), Marginal Zone Lymphoma, Myelofibrosis, Nodal Marginal Zone Lymphoma, Non Hodgkin Lymphoma, PSC, Spinal Column Tumor, Staphylococcus Aureus Bacteremia

Studies at this site

• Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT — Recruiting now
• Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study) — Recruiting now
• Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma — Recruiting now
• Staphylococcus Aureus Network Adaptive Platform Trial — Recruiting now
• Primary Tumor Research and Outcomes Network — Recruiting now
• A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment — Running, not enrolling
• Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL) — Stopped early
• CB-17-08 Augmented Endoscopy System for Mucosal Lesion Detection During Colonoscopy for Colon Rectal Cancer. — Completed
• Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia — Stopped early